Rejoni, Inc., a commercial-stage women's health company focused on uterine health, today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA P250051) for the ...
Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study. This announcement marks a ...
Angelo Hooker, MD, PhD, focuses here on intrauterine adhesions, discussing clinical challenges, management strategies, and ...
Womed Leaf® Resorbable Adhesion Barrier receives PMA approval for women suffering from moderate to severe intrauterine adhesions, a major cause for female infertility MONTPELLIER, France, September 16 ...
Intrauterine adhesions (IUA) arise from inflammation-driven fibrotic remodeling that limits endometrial repair. Mesenchymal stem cells (MSCs) and MSC-derived exosomes are promising, but direct ...
To investigate the effect of pelvic adhesions on reproductive outcomes following high-intensity focused ultrasound (HIFU) ablation in patients with adenomyosis. A total of 396 patients with ...
Chinese researchers have demonstrated new reconstructable uterus-derived materials (RUMs) that allow almost complete recovery from severe uterine injury. Relevant results were published online in ...
MONTPELLIER, France--(BUSINESS WIRE)--Womed, the women's health tech company pioneering innovative treatments against challenging uterine pathologies based on a novel polymer material technology, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results